S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money

Tango Therapeutics (TNGX) Earnings Date, Estimates & Call Transcripts

$7.36
-0.23 (-3.03%)
(As of 04/12/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

TNGX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TNGX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Tango Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.33)($0.31)($0.32)
Q2 20243($0.33)($0.31)($0.32)
Q3 20243($0.35)($0.29)($0.32)
Q4 20243($0.36)($0.28)($0.32)
FY 202412($1.37)($1.19)($1.28)

TNGX Earnings Date and Information

Tango Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Tango Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
11/8/2023Q3 2023($0.34)($0.23)+$0.11($0.23)$8.05 million$10.73 million
8/7/2023Q2 2023($0.33)($0.23)+$0.10($0.23)$7.00 million$14.60 million
5/9/2023Q1 2023($0.36)($0.32)+$0.04($0.32)$6.70 million$5.77 million
3/27/2023Q4 2022($0.36)($0.33)+$0.03($0.33)$6.60 million$6.41 million
11/10/2022Q3 2022($0.32)($0.33)($0.01)($0.33)$5.97 million$6.92 million
8/10/2022Q2 2022($0.33)($0.28)+$0.05($0.28)$5.97 million$5.77 million
5/11/2022Q1 2022($0.28)($0.29)($0.01)($0.29)$6.31 million$5.76 million
3/28/2022Q4 2021($0.28)($0.25)+$0.03($0.25)$6.12 million$5.72 million
11/9/2021Q3 2021($0.26)($0.28)($0.02)($0.28)$6.11 million$6.79 million

Tango Therapeutics Earnings - Frequently Asked Questions

When is Tango Therapeutics's earnings date?

Tango Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on TNGX's earnings history.

How much revenue does Tango Therapeutics generate each year?

Tango Therapeutics (NASDAQ:TNGX) has a recorded annual revenue of $36.53 million.

How much profit does Tango Therapeutics generate each year?

Tango Therapeutics (NASDAQ:TNGX) has a recorded net income of -$101.74 million. TNGX has generated -$1.10 earnings per share over the last four quarters.

What is Tango Therapeutics's EPS forecast for next year?

Tango Therapeutics's earnings are expected to grow from ($1.28) per share to ($1.25) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:TNGX) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners